Cargando…
Effect of ASP2151, a Herpesvirus Helicase-Primase Inhibitor, in a Guinea Pig Model of Genital Herpes
ASP2151 is a herpesvirus helicase-primase inhibitor with antiviral activity against varicella zoster virus and herpes simplex virus types 1 (HSV-1) and 2 (HSV-2). Here, we examined the potency and efficacy of ASP2151 against HSV in vitro and in vivo. We found that ASP2151 was more potent in inhibiti...
Autores principales: | Katsumata, Kiyomitsu, Chono, Koji, Sudo, Kenji, Shimizu, Yasuaki, Kontani, Toru, Suzuki, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6264763/ https://www.ncbi.nlm.nih.gov/pubmed/21869749 http://dx.doi.org/10.3390/molecules16097210 |
Ejemplares similares
-
Absorption, Distribution, Metabolism, and Excretion of the Novel Helicase-Primase Inhibitor, Amenamevir (ASP2151), in Rodents
por: Ohtsu, Yoshiaki, et al.
Publicado: (2018) -
Amenamevir, a Helicase-Primase Inhibitor, for the Optimal Treatment of Herpes Zoster
por: Shiraki, Kimiyasu, et al.
Publicado: (2021) -
The three-component helicase/primase complex of herpes simplex virus-1
por: Bermek, Oya, et al.
Publicado: (2021) -
Primase is required for helicase activity and helicase alters the specificity of primase in the enteropathogen Clostridium difficile
por: van Eijk, Erika, et al.
Publicado: (2016) -
UL52 Primase Interactions in the Herpes Simplex Virus 1 Helicase-Primase Are Affected by Antiviral Compounds and Mutations Causing Drug Resistance
por: Muylaert, Isabella, et al.
Publicado: (2014)